In vitro analysis demonstrates enhanced bactericidal effects against healthcare-associated pathogens, suggesting a new treatment avenue.
The increased potency, broad-spectrum bactericidal action and anti-biofilm properties of these novel synergistic silver-CBC-CBG triple combinations may provide a useful solution for bacterial silver resistance and the control of HAI.
No takes yet. Share an insight, caveat, or question.
Dietrich et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: